Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2967 (LINC02967) is a human gene that encodes a long non-coding RNA (lncRNA). It has been cataloged and approved based on sequence and locus identification. As a member of the lncRNA class, it does not encode a protein and has no known specific biological function, molecular mechanism, or clear disease association reported in current databases or scientific literature. It is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or other protein-coding gene, and has no documented role as a biomarker or direct drug interaction. The gene's primary identifier is "LINC02967," with AL035661.1 and LOC105372578 as alternative names. It is classified as an ncRNA gene, specifically part of the long non-coding RNA family, and resides on chromosome 20 (20p11) in the human genome. No evidence is available in public domain sources to support its function as a receptor, enzyme, or other protein-coding therapy-relevant target. At present, no information suggests misspelling or incorrectness of the target. It is a correctly annotated lncRNA gene based on HGNC and other genomic resources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2967 (LINC02967).